Liza B. John

3.0k citations

27 papers · 2.4k indexed · 1 hit paper · h-index 16

Impact in

Physiology top 0.5%
- Adenosine and Purinergic Signaling
Oncology top 1%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers

Papers in

Immunology 19
- Immune Cell Function and Interaction 12
- Immunotherapy and Immune Responses 9
- T-cell and B-cell Immunology 4
Oncology 19
- CAR-T cell therapy research 14
- Cancer Immunotherapy and Biomarkers 9
- Cancer Cells and Metastasis 2

Co-authors: Phillip K. Darcy Michael H. Kershaw Christel Devaud Paul A. Beavis Mark J. Smyth Alister C. Ward Melvyn T. Chow Connie P.M. Duong
Journals: OncoImmunology (5 papers)Cancer Immunology Research (3 papers)PLoS ONE (2 papers)Cancer Research (2 papers)Molecular Therapy (1 paper)
Partner nations: Australia United States France

In The Last Decade

Liza B. John

25 papers receiving 2.4k citations

Hit Papers

align trajectories log scale

Anti-PD-1 Antibody Therapy Potently Enhances the Eradication of Established Tumors By Gene-Modified T Cells 2013 · 571 citations

Peers

Countries citing papers authored by Liza B. John

Since Specialization

Citations

This map shows the geographic impact of Liza B. John's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liza B. John with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liza B. John more than expected).

Fields of papers citing papers by Liza B. John

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liza B. John. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liza B. John. The network helps show where Liza B. John may publish in the future.

Co-authors

The 25 scholars most cited alongside Liza B. John, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Liza B. John Line = papers co-authored together Liza B. John links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Dual PD-1 and CTLA-4 Checkpoint Blockade Promotes Antitumor Immune Responses through CD4+Foxp3− Cell–Mediated Modulation of CD103+ Dendritic Cells Cancer Immunology Research ·Paul A. Beavis, Melissa A. Henderson, Lauren Giuffrida, Alexander J. Davenport, Emma V. Petley, Imran G. House, Junyun Lai, Kevin Sek, Nicole Milenkovski, Liza B. John, Sherly Mardiana, Clare Y. Slaney, Joseph A. Trapani, Sherene Loi, Michael H. Kershaw, Nicole M. Haynes, Phillip K. Darcy	2018	51
2	A Multifunctional Role for Adjuvant Anti-4-1BB Therapy in Augmenting Antitumor Response by Chimeric Antigen Receptor T Cells Cancer Research ·Sherly Mardiana, Liza B. John, Melissa A. Henderson, Clare Y. Slaney, Bianca von Scheidt, Lauren Giuffrida, Alexander J. Davenport, Joseph A. Trapani, Paul J. Neeson, Sherene Loi, Nicole M. Haynes, Michael H. Kershaw, Paul A. Beavis, Phillip K. Darcy	2017	63
3	Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacy Journal of Clinical Investigation ·Paul A. Beavis, Melissa A. Henderson, Lauren Giuffrida, Jane K. Mills, Kevin Sek, Ryan Cross, Alexander J. Davenport, Liza B. John, Sherly Mardiana, Clare Y. Slaney, Ricky W. Johnstone, Joseph A. Trapani, John Stagg, Sherene Loi, Lev M. Kats, David Gyorki, Michael H. Kershaw, Phillip K. Darcy	2017	259
4	Abstract A105: Cross-talk between tumors can affect responses to therapy Cancer Immunology Research ·Christel Devaud, Jennifer A. Westwood, Liza B. John, Carmen S. Yong, Paul A. Beavis, Linda A. Snyder, Reto A. Schwendener, Darcy Phillip, Michael H. Kershaw	2016	0
5	Adenosine Receptor 2A Blockade Increases the Efficacy of Anti–PD-1 through Enhanced Antitumor T-cell Responses Cancer Immunology Research ·Paul A. Beavis, Nicole Milenkovski, Melissa A. Henderson, Liza B. John, Bertrand Allard, Sherene Loi, Michael H. Kershaw, John Stagg, Phillip K. Darcy	2015	270
6	Cross-talk between tumors can affect responses to therapy. PubMed ·Christel Devaud, Liza B. John, Jennifer A. Westwood, Carmen S. Yong, Paul A. Beavis, Reto A. Schwendener, Phillip K. Darcy, Michael H. Kershaw	2015	8
7	Genetic Modification of Mouse Effector and Helper T Lymphocytes Expressing a Chimeric Antigen Receptor Methods in molecular biology ·Liza B. John, Tess Chee, David E. Gilham, Phillip K. Darcy	2014	2
8	Differential potency of regulatory T cell-mediated immunosuppression in kidney tumors compared to subcutaneous tumors OncoImmunology ·Christel Devaud, Jennifer A. Westwood, Michele W.L. Teng, Liza B. John, Carmen S. Yong, Connie P.M. Duong, Mark J. Smyth, Phillip K. Darcy, Michael H. Kershaw	2014	6
9	Foxp3 Expression in Macrophages Associated with RENCA Tumors in Mice PLoS ONE ·Christel Devaud, Carmen S. Yong, Liza B. John, Jennifer A. Westwood, Connie P.M. Duong, Colin M. House, Delphine Denoyer, Jason Li, Phillip K. Darcy, Michael H. Kershaw	2014	32
10	Anti-PD-1 Antibody Therapy Potently Enhances the Eradication of Established Tumors By Gene-Modified T Cells Clinical Cancer Research ·Liza B. John, Christel Devaud, Connie P.M. Duong, Carmen S. Yong, Paul A. Beavis, Nicole M. Haynes, Melvyn T. Chow, Mark J. Smyth, Michael H. Kershaw, Phillip K. Darcy Hit paper breakdown →	2013	571
11	Immune modulation of the tumor microenvironment for enhancing cancer immunotherapy OncoImmunology ·Christel Devaud, Liza B. John, Jennifer A. Westwood, Phillip K. Darcy, Michael H. Kershaw	2013	172
12	Enhancing immunotherapy using chemotherapy and radiation to modify the tumor microenvironment OncoImmunology ·Michael H. Kershaw, Christel Devaud, Liza B. John, Jennifer A. Westwood, Phillip K. Darcy	2013	83
13	Tissues in Different Anatomical Sites Can Sculpt and Vary the Tumor Microenvironment to Affect Responses to Therapy Molecular Therapy ·Christel Devaud, Jennifer A. Westwood, Liza B. John, Jacqueline K. Flynn, Sophie Paquet‐Fifield, Connie P.M. Duong, Carmen S. Yong, Hollie J. Pegram, Steven A. Stacker, Marc G. Achen, Trina J. Stewart, Linda A. Snyder, Michele W.L. Teng, Mark J. Smyth, Phillip K. Darcy, Michael H. Kershaw	2013	98
14	Blockade of PD-1 immunosuppression boosts CAR T-cell therapy OncoImmunology ·Liza B. John, Michael H. Kershaw, Phillip K. Darcy	2013	114
15	Pegasus, the ‘atypical’ Ikaros family member, influences left–right asymmetry and regulates pitx2 expression Developmental Biology ·Liza B. John, Monique C. Trengove, Fiona Fraser, Simon Yoong, Alister C. Ward	2013	4
16	Engineering T Cell Function Using Chimeric Antigen Receptors Identified Using a DNA Library Approach PLoS ONE ·Connie P.M. Duong, Jennifer A. Westwood, Carmen S. Yong, Amanda J. Murphy, Christel Devaud, Liza B. John, Phillip K. Darcy, Michael H. Kershaw	2013	46
17	Oncolytic Virus and Anti–4-1BB Combination Therapy Elicits Strong Antitumor Immunity against Established Cancer Cancer Research ·Liza B. John, Linda J. Howland, Jacqueline K. Flynn, Alison C. West, Christel Devaud, Connie P.M. Duong, Trina J. Stewart, Jenny A. Westwood, Zong Sheng Guo, David L. Bartlett, Mark J. Smyth, Michael H. Kershaw, Phillip K. Darcy	2012	92
18	Virotherapy, gene transfer and immunostimulatory monoclonal antibodies OncoImmunology ·José I. Quetglas, Liza B. John, Michael H. Kershaw, Luis Álvarez‐Vallina, Ignacio Melero, Phillip K. Darcy, Cristian Smerdou	2012	8
19	Origins of Adaptive Immunity Critical Reviews in Immunology ·Clifford Liongue, Liza B. John, Alister C. Ward	2011	6
20	Evolution of the Ikaros Gene Family: Implications for the Origins of Adaptive Immunity The Journal of Immunology ·Liza B. John, Simon Yoong, Alister C. Ward	2009	20

About Liza B. John

Liza B. John is a scholar working on Immunology, Oncology, Physiology, Genetics and Public Health, Environmental and Occupational Health, having authored 27 papers that have together received 2.4k indexed citations. Recurring topics across this work include CAR-T cell therapy research (14 papers), Immune Cell Function and Interaction (12 papers), Cancer Immunotherapy and Biomarkers (9 papers), Immunotherapy and Immune Responses (9 papers), T-cell and B-cell Immunology (4 papers), Nanowire Synthesis and Applications (3 papers), Cancer Cells and Metastasis (2 papers) and Adenosine and Purinergic Signaling (2 papers). The work is most often cited by research in Physiology (396 citations), Oncology (1.7k citations), Immunology (1.2k citations), Genetics (399 citations) and Molecular Biology (612 citations). Liza B. John has collaborated with scholars based in Australia, United States and France. Frequent co-authors include Phillip K. Darcy, Michael H. Kershaw, Christel Devaud, Paul A. Beavis, Mark J. Smyth, Alister C. Ward, Melvyn T. Chow, Connie P.M. Duong, Carmen S. Yong and Jennifer A. Westwood. Their work appears in journals such as OncoImmunology, Cancer Immunology Research, PLoS ONE, Cancer Research and Molecular Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact